Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Jan;41(1):117–122. doi: 10.1038/bjc.1980.13

Mechanisms of C. Parvum-induced coagulopathy in mice.

H D Mitcheson, P Hilgard, A McCraw, J E Castro
PMCID: PMC2010159  PMID: 7362773

Abstract

I.v. injection of Corynebacterium parvum (CP) into C57BL and BALB/c mice caused profound coagulation changes, featuring thrombocytopenia, decreased fibrinogen, increased fibrin/fibrinogen degradation products, and a concomitant microangiopathic haemolytic anaemia. These changes were greatest on the 9th day after CP, with recovery by Day 21. I.p. injection caused similar effects but s.c. injection was ineffective. Radiolabelled-platelet kinetics and distribution after i.v. CP indicated disseminated intravascular coagulation with rapid fibrinolysis; EACA treatment exacerbated the thrombosis. The coagulopathy correlated with hepatosplenomegaly, and both were dose dependent. Splenectomy did not effect the coagulopathy, but indomethacin totally abrogated the changes, suggesting that prostaglandin biosynthesis is involved in the pathogenesis.

Full text

PDF
117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlam C., Scott M. T. Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria. J Med Microbiol. 1973 Aug;6(3):261–274. doi: 10.1099/00222615-6-3-261. [DOI] [PubMed] [Google Scholar]
  2. BRECHER G., CRONKITE E. P. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950 Dec;3(6):365–377. doi: 10.1152/jappl.1950.3.6.365. [DOI] [PubMed] [Google Scholar]
  3. Brune K., Glatt M., Kälin H., Peskar B. A. Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature. 1978 Jul 20;274(5668):261–263. doi: 10.1038/274261a0. [DOI] [PubMed] [Google Scholar]
  4. Bull B. S., Kuhn I. N. The production of schistocytes by fibrin strands (a scanning electron microscope study). Blood. 1970 Jan;35(1):104–111. [PubMed] [Google Scholar]
  5. Cederholm-Williams S. A., King A., Allington M. J., Gill P. G., Sharp A. A., Britton B. J. Coagulation and fibrinolysis during the infusion of Corynebacterium parvum in man. Br J Cancer. 1978 Jun;37(6):1074–1077. doi: 10.1038/bjc.1978.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cox K. O., Keast D. Studies of the Corynebacterium parvum-associated anaemia in mice. Clin Exp Immunol. 1974 May;17(1):199–207. [PMC free article] [PubMed] [Google Scholar]
  7. Halpern B. N., Biozzi G., Stiffel C., Mouton D. Inhibition of tumour growth by administration of killed corynebacterium parvum. Nature. 1966 Nov 19;212(5064):853–854. doi: 10.1038/212853a0. [DOI] [PubMed] [Google Scholar]
  8. Hawiger J., Niewiarowski S., Gurewich V., Thomas D. P. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J Lab Clin Med. 1970 Jan;75(1):93–108. [PubMed] [Google Scholar]
  9. Jones P. D., Castro J. E. Immunological mechanisms in metastatic spread and the antimetastatic effects of C. parvum. Br J Cancer. 1977 May;35(5):519–527. doi: 10.1038/bjc.1977.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jones P. D., Sadler T. E., Castro J. E. Effect of Corynebacterium parvum on peripheral blood platelets. Br J Cancer. 1977 Dec;36(6):777–782. doi: 10.1038/bjc.1977.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lampert I. A., Jones P. D., Sadler T. E., Castro J. E. Intravascular coagulation resulting from intravenous injection of C. parvum in mice. Br J Cancer. 1977 Jul;36(1):15–22. doi: 10.1038/bjc.1977.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Maruyama Y., Coleman M. S. Induction of spleen cell growth and DNA polymerase activity by Corynebacterium parvum. Cancer Res. 1978 Jun;38(6):1617–1620. [PubMed] [Google Scholar]
  13. McBride W. H., Jones J. T., Weir D. M. Increased phagocytic cell activity and anaemia in Corynebacterium parvum treated mice. Br J Exp Pathol. 1974 Feb;55(1):38–46. [PMC free article] [PubMed] [Google Scholar]
  14. McCracken A., McBride W. H., Weir D. M. Adjuvant-induced antired blood cell activity in CBA mice. Clin Exp Immunol. 1971 Jun;8(6):949–955. [PMC free article] [PubMed] [Google Scholar]
  15. Milas L., Scott M. T. Antitumor activity of Corynebacterium parvum. Adv Cancer Res. 1978;26:257–306. doi: 10.1016/s0065-230x(08)60090-1. [DOI] [PubMed] [Google Scholar]
  16. Proctor J., Rudenstam C. M., Alexander P. Increased incidence of lung metastases following treatment of rats bearing hepatomas with irradiated tumour cells and the benefical effect of Corynebacterium parvum in this system. Biomedicine. 1973 Jun 20;19(6):248–252. [PubMed] [Google Scholar]
  17. Sadler T. E., Castro J. E. The effects of Corynebacterium parvum and surgery on the Lewis lung carcinoma and its metastases. Br J Surg. 1976 Apr;63(4):292–296. doi: 10.1002/bjs.1800630410. [DOI] [PubMed] [Google Scholar]
  18. Smith S. E., Scott M. T. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours. Br J Cancer. 1972 Oct;26(5):361–367. doi: 10.1038/bjc.1972.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Warr G. W., Sljivić V. S. Origin and division of liver macrophages during stimulation of the mononuclear phagocyte system. Cell Tissue Kinet. 1974 Nov;7(6):559–565. doi: 10.1111/j.1365-2184.1974.tb00439.x. [DOI] [PubMed] [Google Scholar]
  20. Woodruff M. F., Boak J. L. Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts. Br J Cancer. 1966 Jun;20(2):345–355. doi: 10.1038/bjc.1966.42. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES